Headlines

Research promising for reducing risk of breast cancer spreading to the brain

New research seeks to better understand why breast cancer spreads to the brain, with the goal of developing a way to reduce the risk of this phenomenon.

Biopsies with DCIS diagnosis increase for women undergoing mammography

Biopsies with DCIS diagnosis increase for women undergoing mammography

Biopsy frequency went up after diagnostic, but not screening, mammographies.

Fear of cancer may have unwanted effect on public screening uptake

Fear of cancer may have unwanted effect on public screening uptake

People who worry about developing cancer are more likely to want to undergo screening for colon cancer.

PDE-5 inhibitors increase risk of biochemical recurrence after radical prostatectomy

PDE-5 inhibitors increase risk of biochemical recurrence after radical prostatectomy

Taking phosphodiesterase type 5 inhibitors following radical prostatectomy is associated with an elevated risk of recurrence.

New minimally invasive device may soon replace endoscopy for Barrett's esophagus diagnosis

New minimally invasive device may soon replace endoscopy for Barrett's esophagus diagnosis

A new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus.

Many breast cancer patients lack basic knowledge about their disease

Many breast cancer patients lack basic knowledge about their disease

Many women with breast cancer lack basic knowledge about their disease, and the problem is more pronounced among minority women.

Children of melanoma survivors need better sun protection

A recent, groundbreaking new study found that children of melanoma survivors are not adhering to sun protection recommendations.

Cancer biopsies found not to promote cancer spread

A recent study may dispel the myth that cancer biopsies have a role in the spreading of cancer in the body.

Effectiveness of nanoparticle drugs was hindered by tumor microenvironment in triple-negative breast cancer

Nanoparticle drugs were considered to be a potential silver bullet against cancer, but they have not produced the anticipated improvement in overall survival rates.

Cancer diagnoses diminishes adherence to diabetes medications

Cancer diagnoses diminishes adherence to diabetes medications

Patients with diabetes become less adherent to their antihyperglycemic medications after receiving a cancer diagnosis.

Conference Coverage

Novel tool predicts postoperative liver cancer recurrence after transplant

The risk of disease recurrence in liver cancer patients who have undergone a liver transplant can now be more accurately calculated, thanks to new tool.

Surgery may not be necessary for some patients with rectal cancer

Patients with rectal cancer that experienced a complete response had similar 4-year survival rates regardless of whether they had immediate surgery or pursued a watch-and-wait approach.

Long-term outcomes improved by combining bevacizumab with newer chemotherapy regimen for advanced colorectal cancer

A phase III study of patients with metastatic colorectal cancer has indicated that FOLFOXIRI chemotherapy, in combination with bevacizumab, is superior to the standard FOLFIRI chemotherapy with bevacizumab.

Young adults with acute lymphoblastic leukemia (ALL) benefit from therapies developed for children

There is increasing evidence that adolescent and young adult patients with acute lymphoblastic leukemia (ALL) tend to fare better when treated with high-intensity pediatric protocols than standard adult regimens.

PRM-151 therapy well tolerated by patients with advanced myelofibrosis

The compound PRM-151 (PRM) has shown success in reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs